| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholera | 113 | 2024 | 754 | 10.360 |
Why?
|
| Vibrio cholerae | 89 | 2023 | 793 | 7.180 |
Why?
|
| Vibrio cholerae O1 | 54 | 2024 | 243 | 5.750 |
Why?
|
| Antibodies, Bacterial | 78 | 2024 | 1477 | 3.950 |
Why?
|
| Cholera Vaccines | 39 | 2024 | 264 | 3.470 |
Why?
|
| O Antigens | 24 | 2024 | 196 | 2.290 |
Why?
|
| Bangladesh | 75 | 2023 | 742 | 2.260 |
Why?
|
| Antigens, Bacterial | 28 | 2019 | 1148 | 1.940 |
Why?
|
| Bacterial Proteins | 46 | 2015 | 3834 | 1.880 |
Why?
|
| Vibrio cholerae O139 | 13 | 2023 | 54 | 1.760 |
Why?
|
| Immunoglobulin A | 50 | 2024 | 992 | 1.660 |
Why?
|
| Cholera Toxin | 40 | 2024 | 562 | 1.640 |
Why?
|
| Immunologic Memory | 24 | 2022 | 1377 | 1.580 |
Why?
|
| Typhoid Fever | 14 | 2020 | 195 | 1.440 |
Why?
|
| Fimbriae Proteins | 15 | 2017 | 133 | 1.440 |
Why?
|
| Gene Expression Regulation, Bacterial | 26 | 2015 | 1137 | 1.430 |
Why?
|
| Genes, Bacterial | 28 | 2012 | 1076 | 1.240 |
Why?
|
| Escherichia coli O157 | 8 | 2015 | 53 | 1.190 |
Why?
|
| Salmonella typhi | 13 | 2020 | 200 | 1.190 |
Why?
|
| Escherichia coli Proteins | 14 | 2016 | 1055 | 1.030 |
Why?
|
| Diarrhea | 19 | 2024 | 1319 | 1.010 |
Why?
|
| Feces | 20 | 2024 | 1508 | 0.960 |
Why?
|
| Immunoglobulin M | 24 | 2024 | 1527 | 0.910 |
Why?
|
| Bacterial Toxins | 20 | 2016 | 922 | 0.900 |
Why?
|
| Immunoglobulin G | 56 | 2024 | 4560 | 0.890 |
Why?
|
| Virulence | 29 | 2015 | 1294 | 0.840 |
Why?
|
| B-Lymphocytes | 23 | 2022 | 4787 | 0.840 |
Why?
|
| Bacterial Outer Membrane Proteins | 16 | 2015 | 404 | 0.810 |
Why?
|
| Caenorhabditis elegans | 13 | 2009 | 1474 | 0.730 |
Why?
|
| Cryptococcus neoformans | 7 | 2009 | 110 | 0.720 |
Why?
|
| Bacteremia | 10 | 2015 | 983 | 0.700 |
Why?
|
| Immunity, Mucosal | 11 | 2020 | 499 | 0.700 |
Why?
|
| Iron | 20 | 2001 | 1811 | 0.690 |
Why?
|
| Escherichia coli Infections | 7 | 2017 | 518 | 0.670 |
Why?
|
| Bacterial Typing Techniques | 5 | 2014 | 263 | 0.670 |
Why?
|
| Antibody-Producing Cells | 8 | 2021 | 140 | 0.640 |
Why?
|
| Endocarditis, Bacterial | 5 | 2013 | 436 | 0.600 |
Why?
|
| Enterococcus faecalis | 8 | 2004 | 244 | 0.600 |
Why?
|
| Enterotoxins | 9 | 2016 | 366 | 0.590 |
Why?
|
| Lipopolysaccharides | 19 | 2023 | 2217 | 0.570 |
Why?
|
| Genome, Bacterial | 8 | 2024 | 796 | 0.530 |
Why?
|
| Blood Group Antigens | 3 | 2023 | 183 | 0.510 |
Why?
|
| Enterotoxigenic Escherichia coli | 5 | 2017 | 32 | 0.500 |
Why?
|
| Vaccines, Conjugate | 11 | 2023 | 334 | 0.490 |
Why?
|
| Bacteriophages | 7 | 2013 | 382 | 0.480 |
Why?
|
| Infectious Disease Medicine | 1 | 2015 | 49 | 0.470 |
Why?
|
| Mutagenesis, Insertional | 11 | 2004 | 661 | 0.470 |
Why?
|
| Vaccines, Synthetic | 9 | 2009 | 621 | 0.460 |
Why?
|
| Regulon | 3 | 1999 | 71 | 0.460 |
Why?
|
| Bacterial Vaccines | 9 | 2009 | 400 | 0.460 |
Why?
|
| History of Medicine | 1 | 2014 | 42 | 0.450 |
Why?
|
| Antibody Formation | 11 | 2024 | 1392 | 0.440 |
Why?
|
| Device Approval | 1 | 2015 | 164 | 0.440 |
Why?
|
| Streptococcus mutans | 1 | 2013 | 99 | 0.430 |
Why?
|
| Receptors, Cell Surface | 9 | 1998 | 2815 | 0.420 |
Why?
|
| Escherichia coli | 19 | 2016 | 4209 | 0.420 |
Why?
|
| Vaccination | 12 | 2024 | 3434 | 0.410 |
Why?
|
| Adhesins, Bacterial | 4 | 2012 | 118 | 0.410 |
Why?
|
| Immunoglobulin A, Secretory | 2 | 2003 | 105 | 0.410 |
Why?
|
| Repressor Proteins | 10 | 2001 | 2979 | 0.410 |
Why?
|
| Disease Outbreaks | 9 | 2018 | 1761 | 0.400 |
Why?
|
| Vaccines, Attenuated | 10 | 2017 | 314 | 0.400 |
Why?
|
| DNA, Bacterial | 19 | 2015 | 1477 | 0.400 |
Why?
|
| Molecular Sequence Data | 35 | 2015 | 17608 | 0.380 |
Why?
|
| Oxazoles | 4 | 2000 | 198 | 0.370 |
Why?
|
| Government Regulation | 1 | 2015 | 525 | 0.370 |
Why?
|
| Streptococcal Infections | 3 | 2013 | 618 | 0.360 |
Why?
|
| Bone Marrow Transplantation | 10 | 2004 | 2710 | 0.360 |
Why?
|
| Antibodies, Protozoan | 4 | 2012 | 251 | 0.360 |
Why?
|
| Child, Preschool | 63 | 2024 | 42606 | 0.360 |
Why?
|
| Operon | 4 | 2000 | 371 | 0.350 |
Why?
|
| T-Lymphocyte Subsets | 5 | 2018 | 1814 | 0.350 |
Why?
|
| Fimbriae, Bacterial | 3 | 2005 | 138 | 0.340 |
Why?
|
| Catechols | 4 | 2000 | 63 | 0.340 |
Why?
|
| Immunity, Innate | 9 | 2019 | 3076 | 0.340 |
Why?
|
| Administration, Oral | 20 | 2021 | 4026 | 0.340 |
Why?
|
| Disease Susceptibility | 4 | 2021 | 1791 | 0.340 |
Why?
|
| Cryptosporidiosis | 4 | 2012 | 52 | 0.340 |
Why?
|
| Base Sequence | 27 | 2013 | 12414 | 0.340 |
Why?
|
| Communicable Diseases | 2 | 2017 | 872 | 0.330 |
Why?
|
| DNA-Binding Proteins | 10 | 2003 | 9612 | 0.320 |
Why?
|
| Gene Expression Profiling | 12 | 2018 | 9532 | 0.320 |
Why?
|
| Disease Models, Animal | 16 | 2021 | 18330 | 0.320 |
Why?
|
| Adolescent | 74 | 2024 | 89046 | 0.320 |
Why?
|
| Serologic Tests | 3 | 2020 | 382 | 0.320 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2009 | 64 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2009 | 127 | 0.310 |
Why?
|
| Shiga Toxins | 7 | 1999 | 39 | 0.310 |
Why?
|
| Vaccines, Inactivated | 11 | 2023 | 186 | 0.310 |
Why?
|
| Humans | 197 | 2024 | 767040 | 0.310 |
Why?
|
| Drug Approval | 1 | 2015 | 820 | 0.300 |
Why?
|
| Paratyphoid Fever | 3 | 2013 | 34 | 0.300 |
Why?
|
| Helminthiasis | 1 | 2009 | 81 | 0.300 |
Why?
|
| Transcription Factors | 12 | 2003 | 12158 | 0.300 |
Why?
|
| Gastrointestinal Tract | 4 | 2024 | 837 | 0.300 |
Why?
|
| Drug Discovery | 1 | 2015 | 1068 | 0.290 |
Why?
|
| Transcription, Genetic | 14 | 2007 | 7611 | 0.280 |
Why?
|
| Antibody Specificity | 4 | 2019 | 1062 | 0.280 |
Why?
|
| Adult | 91 | 2024 | 223317 | 0.280 |
Why?
|
| Mucous Membrane | 5 | 2019 | 659 | 0.280 |
Why?
|
| Proteome | 5 | 2013 | 1890 | 0.280 |
Why?
|
| United States Food and Drug Administration | 1 | 2015 | 1672 | 0.280 |
Why?
|
| Genes, Regulator | 4 | 1998 | 373 | 0.280 |
Why?
|
| Child | 64 | 2024 | 80771 | 0.280 |
Why?
|
| Disease Transmission, Infectious | 3 | 2011 | 560 | 0.270 |
Why?
|
| Heart Valve Prosthesis | 6 | 2001 | 1464 | 0.270 |
Why?
|
| Genetic Complementation Test | 9 | 2002 | 556 | 0.270 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 705 | 0.270 |
Why?
|
| Antibodies, Viral | 4 | 2022 | 3212 | 0.270 |
Why?
|
| Systems Biology | 1 | 2010 | 481 | 0.270 |
Why?
|
| Immune Sera | 2 | 2015 | 605 | 0.270 |
Why?
|
| Cryptosporidium | 4 | 2012 | 43 | 0.260 |
Why?
|
| Amino Acid Sequence | 23 | 2013 | 13411 | 0.260 |
Why?
|
| Neuraminidase | 3 | 2022 | 192 | 0.260 |
Why?
|
| Education, Medical, Graduate | 2 | 2017 | 2420 | 0.260 |
Why?
|
| Family Characteristics | 8 | 2018 | 1002 | 0.260 |
Why?
|
| Duodenum | 5 | 2022 | 495 | 0.250 |
Why?
|
| Chromosomes, Bacterial | 5 | 2013 | 281 | 0.250 |
Why?
|
| Intestines | 7 | 2015 | 1905 | 0.250 |
Why?
|
| Immunity, Humoral | 2 | 2020 | 610 | 0.250 |
Why?
|
| Young Adult | 47 | 2021 | 59980 | 0.250 |
Why?
|
| Recombinant Proteins | 10 | 2016 | 6507 | 0.240 |
Why?
|
| Promoter Regions, Genetic | 14 | 2009 | 5796 | 0.240 |
Why?
|
| Neutropenia | 3 | 2001 | 892 | 0.240 |
Why?
|
| Travel | 2 | 2001 | 805 | 0.230 |
Why?
|
| Prosthesis-Related Infections | 2 | 2001 | 497 | 0.230 |
Why?
|
| Endophthalmitis | 3 | 2004 | 263 | 0.230 |
Why?
|
| Vaccines, Combined | 2 | 2021 | 70 | 0.230 |
Why?
|
| Salmonella paratyphi A | 3 | 2016 | 47 | 0.230 |
Why?
|
| Staphylococcus aureus | 5 | 2006 | 1429 | 0.230 |
Why?
|
| Plasmids | 7 | 2017 | 2268 | 0.230 |
Why?
|
| Antibody Affinity | 3 | 2014 | 251 | 0.220 |
Why?
|
| Female | 110 | 2022 | 396660 | 0.220 |
Why?
|
| Immunity, Cellular | 2 | 2009 | 1560 | 0.220 |
Why?
|
| Shigella Vaccines | 1 | 2023 | 10 | 0.220 |
Why?
|
| Carrier State | 2 | 2020 | 529 | 0.220 |
Why?
|
| Convalescence | 3 | 2021 | 107 | 0.220 |
Why?
|
| RNA, Bacterial | 7 | 2011 | 393 | 0.220 |
Why?
|
| Bacteriological Techniques | 2 | 2018 | 277 | 0.220 |
Why?
|
| Fungal Proteins | 2 | 2004 | 901 | 0.210 |
Why?
|
| Biological Assay | 2 | 2004 | 626 | 0.210 |
Why?
|
| Mice | 42 | 2023 | 81912 | 0.210 |
Why?
|
| Polymerase Chain Reaction | 8 | 2018 | 6067 | 0.210 |
Why?
|
| Male | 93 | 2022 | 364203 | 0.210 |
Why?
|
| Shigella | 1 | 2023 | 69 | 0.210 |
Why?
|
| Animals | 69 | 2023 | 168965 | 0.210 |
Why?
|
| Dysentery, Bacillary | 1 | 2023 | 73 | 0.210 |
Why?
|
| T-Lymphocytes | 7 | 2015 | 10254 | 0.200 |
Why?
|
| Gene Deletion | 6 | 2013 | 2668 | 0.200 |
Why?
|
| Polymorphism, Genetic | 3 | 2011 | 4247 | 0.200 |
Why?
|
| Societies, Medical | 1 | 2015 | 3964 | 0.200 |
Why?
|
| Ferrichrome | 2 | 2000 | 3 | 0.200 |
Why?
|
| Staphylococcus epidermidis | 3 | 2007 | 121 | 0.200 |
Why?
|
| Genetic Vectors | 7 | 2000 | 3402 | 0.200 |
Why?
|
| Enzyme-Linked Immunospot Assay | 3 | 2017 | 126 | 0.200 |
Why?
|
| Antigens, Protozoan | 3 | 2012 | 315 | 0.200 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2002 | 167 | 0.190 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1996 | 892 | 0.190 |
Why?
|
| Cloning, Molecular | 11 | 2002 | 4167 | 0.190 |
Why?
|
| Bacterial Adhesion | 4 | 2015 | 306 | 0.190 |
Why?
|
| Pseudomonas aeruginosa | 4 | 2003 | 1277 | 0.190 |
Why?
|
| Infant | 34 | 2021 | 36485 | 0.190 |
Why?
|
| Listeriosis | 2 | 2002 | 147 | 0.190 |
Why?
|
| Entamoeba histolytica | 2 | 2000 | 28 | 0.190 |
Why?
|
| Genetic Variation | 6 | 2024 | 6611 | 0.190 |
Why?
|
| Salmonella enterica | 2 | 2016 | 75 | 0.190 |
Why?
|
| Anthozoa | 1 | 2021 | 65 | 0.180 |
Why?
|
| Colony Count, Microbial | 3 | 2012 | 325 | 0.180 |
Why?
|
| Parasitic Diseases | 1 | 2021 | 76 | 0.180 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2021 | 158 | 0.180 |
Why?
|
| Phylogeny | 9 | 2024 | 2840 | 0.180 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 2001 | 53 | 0.180 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 2004 | 340 | 0.180 |
Why?
|
| Typhoid-Paratyphoid Vaccines | 1 | 2020 | 40 | 0.180 |
Why?
|
| Fungi | 1 | 2003 | 346 | 0.170 |
Why?
|
| Restriction Mapping | 8 | 1997 | 848 | 0.170 |
Why?
|
| Carrier Proteins | 4 | 1999 | 4925 | 0.170 |
Why?
|
| Peroxidase | 2 | 2021 | 610 | 0.170 |
Why?
|
| Contact Tracing | 2 | 2014 | 274 | 0.170 |
Why?
|
| Blood Bactericidal Activity | 6 | 2012 | 124 | 0.170 |
Why?
|
| RNA, Messenger | 11 | 2016 | 12793 | 0.170 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2000 | 76 | 0.170 |
Why?
|
| Peptide Synthases | 1 | 2000 | 81 | 0.170 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2019 | 23 | 0.170 |
Why?
|
| Polysaccharides, Bacterial | 4 | 2020 | 582 | 0.170 |
Why?
|
| Antibodies, Monoclonal | 4 | 2021 | 9245 | 0.160 |
Why?
|
| Species Specificity | 8 | 2015 | 2412 | 0.160 |
Why?
|
| Metagenomics | 2 | 2021 | 473 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2017 | 1854 | 0.160 |
Why?
|
| Sequence Homology, Nucleic Acid | 8 | 2005 | 1057 | 0.160 |
Why?
|
| Staphylococcal Infections | 5 | 2007 | 1396 | 0.160 |
Why?
|
| Bacteria | 4 | 2006 | 2212 | 0.160 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2002 | 566 | 0.150 |
Why?
|
| Membrane Proteins | 5 | 2009 | 7868 | 0.150 |
Why?
|
| Blood | 2 | 2011 | 596 | 0.150 |
Why?
|
| Gene Transfer, Horizontal | 2 | 2017 | 148 | 0.150 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 4 | 2004 | 142 | 0.150 |
Why?
|
| Middle Aged | 54 | 2022 | 223233 | 0.150 |
Why?
|
| Gene Library | 4 | 2006 | 1065 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2020 | 3804 | 0.150 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2001 | 631 | 0.150 |
Why?
|
| Immunoassay | 2 | 2020 | 744 | 0.150 |
Why?
|
| Meningoencephalitis | 1 | 1998 | 82 | 0.150 |
Why?
|
| Protozoan Vaccines | 1 | 1997 | 13 | 0.150 |
Why?
|
| Haiti | 6 | 2017 | 553 | 0.140 |
Why?
|
| Molecular Typing | 2 | 2015 | 115 | 0.140 |
Why?
|
| Leukemia, Myeloid | 2 | 2001 | 693 | 0.140 |
Why?
|
| Transformation, Bacterial | 2 | 2015 | 79 | 0.140 |
Why?
|
| Adenosine Triphosphatases | 1 | 2002 | 840 | 0.140 |
Why?
|
| Alkaline Phosphatase | 6 | 2000 | 861 | 0.140 |
Why?
|
| Cervix Uteri | 1 | 2001 | 575 | 0.140 |
Why?
|
| Models, Animal | 2 | 2003 | 2121 | 0.140 |
Why?
|
| Culture Media | 3 | 2010 | 892 | 0.140 |
Why?
|
| Shiga Toxin 1 | 9 | 1995 | 42 | 0.140 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2002 | 2745 | 0.140 |
Why?
|
| Rabbits | 7 | 2010 | 4751 | 0.140 |
Why?
|
| Adjuvants, Immunologic | 3 | 2012 | 998 | 0.140 |
Why?
|
| Hemolysin Proteins | 1 | 1997 | 113 | 0.140 |
Why?
|
| Lymphocytes | 3 | 2022 | 2605 | 0.140 |
Why?
|
| Tropical Medicine | 1 | 2017 | 52 | 0.140 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2019 | 393 | 0.140 |
Why?
|
| Microbial Viability | 4 | 2011 | 236 | 0.140 |
Why?
|
| DNA Primers | 6 | 2009 | 2827 | 0.140 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 1997 | 88 | 0.140 |
Why?
|
| Cryptococcosis | 3 | 2009 | 99 | 0.130 |
Why?
|
| DNA Helicases | 1 | 2002 | 854 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2001 | 3738 | 0.130 |
Why?
|
| Bacillus anthracis | 2 | 2008 | 120 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 9 | 2015 | 4780 | 0.130 |
Why?
|
| Moths | 2 | 2007 | 82 | 0.130 |
Why?
|
| Endocarditis | 3 | 2001 | 352 | 0.130 |
Why?
|
| Trisaccharides | 1 | 1996 | 50 | 0.130 |
Why?
|
| Urban Population | 1 | 2004 | 2044 | 0.130 |
Why?
|
| HLA-DR Antigens | 1 | 2017 | 609 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 14 | 2015 | 7469 | 0.130 |
Why?
|
| Hybridization, Genetic | 1 | 2015 | 102 | 0.130 |
Why?
|
| Clinical Clerkship | 1 | 2022 | 569 | 0.130 |
Why?
|
| DNA Probes | 1 | 2016 | 541 | 0.120 |
Why?
|
| Tetanus Toxin | 1 | 2015 | 46 | 0.120 |
Why?
|
| Virulence Factors | 4 | 2011 | 498 | 0.120 |
Why?
|
| Interferon-gamma | 3 | 2014 | 3154 | 0.120 |
Why?
|
| Mutagenesis | 5 | 2002 | 1227 | 0.120 |
Why?
|
| Integrin beta Chains | 1 | 2015 | 115 | 0.120 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2015 | 52 | 0.120 |
Why?
|
| Blotting, Southern | 6 | 2001 | 775 | 0.120 |
Why?
|
| Intestinal Mucosa | 4 | 2022 | 3043 | 0.120 |
Why?
|
| Bacterial Shedding | 1 | 2014 | 10 | 0.120 |
Why?
|
| Intestine, Small | 4 | 2012 | 1217 | 0.120 |
Why?
|
| Magnetite Nanoparticles | 1 | 2016 | 310 | 0.120 |
Why?
|
| Plasma | 1 | 2018 | 583 | 0.120 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2004 | 1559 | 0.120 |
Why?
|
| Administration, Cutaneous | 6 | 2020 | 715 | 0.120 |
Why?
|
| Cytotoxins | 2 | 2001 | 154 | 0.110 |
Why?
|
| Siderophores | 1 | 1994 | 61 | 0.110 |
Why?
|
| Receptors, Virus | 2 | 2012 | 652 | 0.110 |
Why?
|
| Sequence Deletion | 5 | 2006 | 1494 | 0.110 |
Why?
|
| Cohort Studies | 14 | 2022 | 41718 | 0.110 |
Why?
|
| Gastrointestinal Diseases | 3 | 2021 | 1205 | 0.110 |
Why?
|
| Fresh Water | 3 | 2009 | 82 | 0.110 |
Why?
|
| Biofilms | 2 | 2010 | 641 | 0.110 |
Why?
|
| Microbial Sensitivity Tests | 6 | 2010 | 1969 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2013 | 18063 | 0.110 |
Why?
|
| Protozoan Proteins | 2 | 2011 | 843 | 0.110 |
Why?
|
| Gelatinases | 2 | 2004 | 93 | 0.110 |
Why?
|
| DNA Transposable Elements | 7 | 2009 | 763 | 0.110 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2018 | 976 | 0.110 |
Why?
|
| Salmonella typhimurium | 2 | 2009 | 348 | 0.110 |
Why?
|
| Vibrio | 1 | 1993 | 40 | 0.100 |
Why?
|
| Genes, Fungal | 2 | 2005 | 440 | 0.100 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 505 | 0.100 |
Why?
|
| Family Health | 3 | 2018 | 1254 | 0.100 |
Why?
|
| Streptococcus | 3 | 1989 | 197 | 0.100 |
Why?
|
| Biliary Tract | 1 | 2013 | 136 | 0.100 |
Why?
|
| Immunization | 5 | 2015 | 1218 | 0.100 |
Why?
|
| Operator Regions, Genetic | 2 | 1990 | 33 | 0.100 |
Why?
|
| Bacteriolysis | 2 | 2013 | 51 | 0.100 |
Why?
|
| Intestinal Diseases | 1 | 2016 | 505 | 0.100 |
Why?
|
| Multigene Family | 3 | 2005 | 1081 | 0.100 |
Why?
|
| Chromosome Mapping | 6 | 2010 | 4616 | 0.100 |
Why?
|
| Genes, Viral | 1 | 2013 | 654 | 0.100 |
Why?
|
| Animals, Suckling | 3 | 2020 | 69 | 0.100 |
Why?
|
| Epithelial Cells | 2 | 2015 | 3698 | 0.090 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2016 | 615 | 0.090 |
Why?
|
| Dehydration | 2 | 2010 | 216 | 0.090 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 1217 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 3 | 2015 | 1466 | 0.090 |
Why?
|
| Immunodominant Epitopes | 1 | 2012 | 244 | 0.090 |
Why?
|
| Mice, Inbred Strains | 3 | 2005 | 1765 | 0.090 |
Why?
|
| Th1 Cells | 3 | 2012 | 1040 | 0.090 |
Why?
|
| Vancomycin | 4 | 2001 | 504 | 0.090 |
Why?
|
| Cytokines | 6 | 2019 | 7446 | 0.090 |
Why?
|
| Antitoxins | 3 | 2019 | 75 | 0.090 |
Why?
|
| Respiratory Insufficiency | 1 | 1999 | 1240 | 0.090 |
Why?
|
| Virus Shedding | 1 | 2011 | 110 | 0.090 |
Why?
|
| Membrane Transport Proteins | 1 | 1996 | 1029 | 0.090 |
Why?
|
| Mutation | 22 | 2015 | 30211 | 0.090 |
Why?
|
| Th2 Cells | 3 | 2012 | 1077 | 0.090 |
Why?
|
| Gene Expression Regulation | 7 | 2019 | 11923 | 0.090 |
Why?
|
| Evolution, Molecular | 4 | 2017 | 1893 | 0.090 |
Why?
|
| Monocytes | 1 | 2019 | 2598 | 0.080 |
Why?
|
| Germ-Free Life | 3 | 2000 | 187 | 0.080 |
Why?
|
| Oligosaccharides | 1 | 2012 | 406 | 0.080 |
Why?
|
| Minisatellite Repeats | 1 | 2010 | 162 | 0.080 |
Why?
|
| Agglutination | 2 | 2020 | 42 | 0.080 |
Why?
|
| Spirochaetales Infections | 1 | 2009 | 11 | 0.080 |
Why?
|
| Immunization, Secondary | 3 | 2021 | 373 | 0.080 |
Why?
|
| DNA Footprinting | 2 | 2000 | 97 | 0.080 |
Why?
|
| Immunization Schedule | 2 | 2020 | 228 | 0.080 |
Why?
|
| Animals, Newborn | 4 | 2011 | 2677 | 0.080 |
Why?
|
| Glucuronidase | 2 | 2001 | 205 | 0.080 |
Why?
|
| Receptors, Scavenger | 1 | 2009 | 123 | 0.080 |
Why?
|
| Severity of Illness Index | 4 | 2022 | 15925 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2012 | 16036 | 0.080 |
Why?
|
| Antibiosis | 1 | 2008 | 46 | 0.080 |
Why?
|
| Signal Transduction | 6 | 2018 | 23621 | 0.080 |
Why?
|
| Quorum Sensing | 1 | 2010 | 137 | 0.080 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2008 | 80 | 0.080 |
Why?
|
| Floods | 1 | 2008 | 42 | 0.080 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 1135 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2011 | 3797 | 0.080 |
Why?
|
| Serotyping | 4 | 2015 | 331 | 0.080 |
Why?
|
| Vitamin A | 2 | 2008 | 611 | 0.080 |
Why?
|
| Fluid Therapy | 1 | 2012 | 587 | 0.080 |
Why?
|
| Curriculum | 1 | 2022 | 3786 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2015 | 2183 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2014 | 1574 | 0.070 |
Why?
|
| Respiration, Artificial | 1 | 1999 | 2726 | 0.070 |
Why?
|
| Rotavirus | 1 | 2008 | 110 | 0.070 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2013 | 788 | 0.070 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2009 | 149 | 0.070 |
Why?
|
| Zinc | 2 | 2008 | 675 | 0.070 |
Why?
|
| Exosomes | 1 | 2011 | 417 | 0.070 |
Why?
|
| Leptin | 1 | 2015 | 1599 | 0.070 |
Why?
|
| Age Distribution | 2 | 2014 | 2870 | 0.070 |
Why?
|
| Tularemia | 1 | 2007 | 40 | 0.070 |
Why?
|
| Cross Reactions | 2 | 2020 | 828 | 0.070 |
Why?
|
| Time Factors | 11 | 2014 | 40154 | 0.070 |
Why?
|
| Acute Disease | 6 | 2018 | 7236 | 0.070 |
Why?
|
| Cluster Analysis | 2 | 2011 | 2721 | 0.070 |
Why?
|
| Francisella tularensis | 1 | 2007 | 60 | 0.070 |
Why?
|
| Azlocillin | 2 | 1984 | 19 | 0.070 |
Why?
|
| Vitamin K 3 | 1 | 2006 | 14 | 0.070 |
Why?
|
| Enterococcus faecium | 2 | 2004 | 101 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2014 | 2765 | 0.070 |
Why?
|
| Quinolones | 1 | 2009 | 389 | 0.070 |
Why?
|
| Serum Bactericidal Test | 1 | 2005 | 3 | 0.070 |
Why?
|
| Hemin | 1 | 2006 | 51 | 0.060 |
Why?
|
| Heat-Shock Proteins | 1 | 1990 | 792 | 0.060 |
Why?
|
| Anthrax Vaccines | 1 | 2005 | 13 | 0.060 |
Why?
|
| Cells, Cultured | 7 | 2015 | 18989 | 0.060 |
Why?
|
| Proteomics | 4 | 2016 | 3913 | 0.060 |
Why?
|
| Infant, Newborn | 8 | 2024 | 26396 | 0.060 |
Why?
|
| Caenorhabditis elegans Proteins | 4 | 2009 | 882 | 0.060 |
Why?
|
| Candida albicans | 1 | 2009 | 376 | 0.060 |
Why?
|
| Th17 Cells | 3 | 2022 | 790 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2009 | 1160 | 0.060 |
Why?
|
| Sequence Alignment | 4 | 2012 | 2176 | 0.060 |
Why?
|
| Chemotaxis | 2 | 2006 | 598 | 0.060 |
Why?
|
| Sensitivity and Specificity | 5 | 2020 | 14672 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2001 | 2478 | 0.060 |
Why?
|
| Flow Cytometry | 3 | 2013 | 5891 | 0.060 |
Why?
|
| Lac Operon | 2 | 2015 | 237 | 0.060 |
Why?
|
| Single-Cell Analysis | 1 | 2016 | 2538 | 0.060 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2009 | 592 | 0.060 |
Why?
|
| Genomic Library | 1 | 2005 | 189 | 0.060 |
Why?
|
| Mice, Inbred ICR | 2 | 2002 | 361 | 0.060 |
Why?
|
| Melanins | 2 | 2007 | 291 | 0.060 |
Why?
|
| Immunologic Techniques | 1 | 2005 | 213 | 0.060 |
Why?
|
| Communicable Disease Control | 1 | 2011 | 856 | 0.060 |
Why?
|
| Bacterial Capsules | 1 | 2005 | 247 | 0.060 |
Why?
|
| Pedigree | 2 | 2009 | 4539 | 0.060 |
Why?
|
| Mucins | 1 | 2007 | 569 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 1531 | 0.060 |
Why?
|
| Bone Marrow | 1 | 1994 | 2926 | 0.060 |
Why?
|
| Odds Ratio | 3 | 2021 | 9660 | 0.060 |
Why?
|
| Risk Factors | 12 | 2022 | 74886 | 0.060 |
Why?
|
| Linkage Disequilibrium | 1 | 2009 | 1996 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2004 | 482 | 0.060 |
Why?
|
| Immunosorbent Techniques | 1 | 2003 | 174 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2014 | 5499 | 0.050 |
Why?
|
| Reproducibility of Results | 5 | 2020 | 20169 | 0.050 |
Why?
|
| Hemagglutinins | 1 | 2003 | 111 | 0.050 |
Why?
|
| Laccase | 1 | 2002 | 7 | 0.050 |
Why?
|
| Genes, Mating Type, Fungal | 1 | 2002 | 25 | 0.050 |
Why?
|
| Cryptococcus | 1 | 2002 | 28 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2008 | 2276 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3112 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3234 | 0.050 |
Why?
|
| Haplotypes | 1 | 2009 | 2722 | 0.050 |
Why?
|
| Bacterial Load | 2 | 2014 | 155 | 0.050 |
Why?
|
| Microscopy | 1 | 2007 | 903 | 0.050 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2002 | 94 | 0.050 |
Why?
|
| Shigella flexneri | 1 | 2023 | 118 | 0.050 |
Why?
|
| Lysogeny | 1 | 2002 | 68 | 0.050 |
Why?
|
| Survival Analysis | 7 | 2012 | 10092 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 4405 | 0.050 |
Why?
|
| Mannose-Binding Lectin | 1 | 2003 | 146 | 0.050 |
Why?
|
| Anti-Infective Agents | 2 | 2001 | 986 | 0.050 |
Why?
|
| Case-Control Studies | 6 | 2017 | 22254 | 0.050 |
Why?
|
| Chromatography, Affinity | 2 | 2010 | 524 | 0.050 |
Why?
|
| Survival Rate | 5 | 2004 | 12823 | 0.050 |
Why?
|
| Bartonella | 1 | 2001 | 11 | 0.050 |
Why?
|
| ROC Curve | 2 | 2021 | 3618 | 0.050 |
Why?
|
| Eye | 2 | 2004 | 711 | 0.050 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2005 | 572 | 0.050 |
Why?
|
| Levodopa | 1 | 2002 | 221 | 0.050 |
Why?
|
| Bone Marrow Purging | 1 | 2001 | 108 | 0.050 |
Why?
|
| Gene Frequency | 1 | 2009 | 3621 | 0.050 |
Why?
|
| Free Radical Scavengers | 1 | 2002 | 213 | 0.050 |
Why?
|
| Cattle | 3 | 2015 | 3813 | 0.050 |
Why?
|
| Incidence | 5 | 2019 | 21526 | 0.050 |
Why?
|
| Genotype | 3 | 2015 | 13035 | 0.050 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 665 | 0.050 |
Why?
|
| Lymphocyte Count | 2 | 2001 | 793 | 0.050 |
Why?
|
| Amikacin | 1 | 1981 | 48 | 0.050 |
Why?
|
| Kanamycin | 1 | 1981 | 63 | 0.050 |
Why?
|
| Aged | 15 | 2024 | 171319 | 0.050 |
Why?
|
| Roseolovirus Infections | 1 | 2001 | 50 | 0.050 |
Why?
|
| Drug Design | 1 | 2006 | 1045 | 0.050 |
Why?
|
| Herpesvirus 6, Human | 1 | 2001 | 96 | 0.050 |
Why?
|
| Binding Sites, Antibody | 1 | 2021 | 340 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2004 | 740 | 0.040 |
Why?
|
| Hospitals | 2 | 2017 | 3883 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2001 | 102 | 0.040 |
Why?
|
| Life Tables | 2 | 2001 | 367 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2014 | 12069 | 0.040 |
Why?
|
| Artificial Gene Fusion | 1 | 2000 | 56 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2002 | 409 | 0.040 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2006 | 283 | 0.040 |
Why?
|
| Bacterial Infections | 2 | 2000 | 1390 | 0.040 |
Why?
|
| United States | 4 | 2018 | 72971 | 0.040 |
Why?
|
| Splenomegaly | 1 | 2001 | 191 | 0.040 |
Why?
|
| Risk | 3 | 2007 | 9606 | 0.040 |
Why?
|
| Mycoses | 2 | 2001 | 386 | 0.040 |
Why?
|
| Genetic Techniques | 1 | 2003 | 427 | 0.040 |
Why?
|
| Disasters | 1 | 2006 | 521 | 0.040 |
Why?
|
| Vaccines, Subunit | 1 | 2000 | 159 | 0.040 |
Why?
|
| Neutrophils | 3 | 2022 | 3779 | 0.040 |
Why?
|
| Rivers | 2 | 2013 | 65 | 0.040 |
Why?
|
| Macrophages | 3 | 2009 | 5785 | 0.040 |
Why?
|
| Alleles | 2 | 2009 | 6893 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2022 | 425 | 0.040 |
Why?
|
| Metronidazole | 1 | 2001 | 236 | 0.040 |
Why?
|
| Drug Evaluation | 1 | 2001 | 641 | 0.040 |
Why?
|
| Serum | 2 | 2011 | 206 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2003 | 839 | 0.040 |
Why?
|
| Antigens | 1 | 2005 | 1442 | 0.040 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2021 | 335 | 0.040 |
Why?
|
| Vision, Ocular | 1 | 2002 | 457 | 0.040 |
Why?
|
| Meningitis, Listeria | 1 | 1998 | 4 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2004 | 1027 | 0.040 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2001 | 264 | 0.040 |
Why?
|
| Inflammasomes | 2 | 2015 | 540 | 0.040 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 1999 | 93 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2004 | 1526 | 0.040 |
Why?
|
| Exotoxins | 1 | 1999 | 123 | 0.040 |
Why?
|
| Endotoxins | 1 | 2021 | 519 | 0.040 |
Why?
|
| HeLa Cells | 3 | 1999 | 3073 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 1990 | 1550 | 0.040 |
Why?
|
| Anemia, Aplastic | 1 | 2000 | 231 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2005 | 1836 | 0.040 |
Why?
|
| Genes, Overlapping | 1 | 1998 | 36 | 0.040 |
Why?
|
| Binding Sites | 3 | 2000 | 6014 | 0.040 |
Why?
|
| Oxacillin | 1 | 1998 | 41 | 0.040 |
Why?
|
| Consensus Sequence | 2 | 1999 | 363 | 0.040 |
Why?
|
| beta-Lactamases | 2 | 2015 | 307 | 0.040 |
Why?
|
| Longevity | 2 | 2003 | 1083 | 0.040 |
Why?
|
| Coagulase | 1 | 1998 | 53 | 0.040 |
Why?
|
| RNA Stability | 1 | 2000 | 319 | 0.040 |
Why?
|
| Recurrence | 5 | 2004 | 8504 | 0.040 |
Why?
|
| Ofloxacin | 1 | 1998 | 66 | 0.040 |
Why?
|
| Phosphotransferases (Nitrogenous Group Acceptor) | 1 | 2017 | 5 | 0.040 |
Why?
|
| Digestive System | 3 | 2004 | 244 | 0.040 |
Why?
|
| Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 2017 | 23 | 0.040 |
Why?
|
| Staphylococcus | 1 | 1998 | 145 | 0.040 |
Why?
|
| Probability | 2 | 2002 | 2476 | 0.040 |
Why?
|
| Brain Abscess | 1 | 1998 | 122 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4572 | 0.040 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2000 | 235 | 0.040 |
Why?
|
| Pneumonia, Bacterial | 1 | 2000 | 319 | 0.040 |
Why?
|
| Central Nervous System Diseases | 1 | 2001 | 518 | 0.030 |
Why?
|
| Phosphoglycerate Kinase | 1 | 1997 | 66 | 0.030 |
Why?
|
| Prospective Studies | 7 | 2018 | 54886 | 0.030 |
Why?
|
| Metagenome | 1 | 2021 | 464 | 0.030 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1997 | 79 | 0.030 |
Why?
|
| CD40 Ligand | 1 | 2018 | 528 | 0.030 |
Why?
|
| Biological Evolution | 2 | 2013 | 1075 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 1998 | 751 | 0.030 |
Why?
|
| Glutamine | 1 | 2000 | 575 | 0.030 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2018 | 238 | 0.030 |
Why?
|
| Flagellin | 1 | 2017 | 124 | 0.030 |
Why?
|
| Ribosomes | 1 | 2000 | 497 | 0.030 |
Why?
|
| Multiple Organ Failure | 1 | 1999 | 389 | 0.030 |
Why?
|
| Asia | 1 | 2018 | 629 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 2011 | 6226 | 0.030 |
Why?
|
| Proteins | 1 | 2011 | 6001 | 0.030 |
Why?
|
| Heart Valve Diseases | 3 | 1991 | 1029 | 0.030 |
Why?
|
| Gene Expression | 3 | 2000 | 7587 | 0.030 |
Why?
|
| P Blood-Group System | 1 | 1996 | 3 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2006 | 2931 | 0.030 |
Why?
|
| Vero Cells | 1 | 1997 | 486 | 0.030 |
Why?
|
| Hemocytes | 2 | 2007 | 48 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2016 | 3684 | 0.030 |
Why?
|
| Synteny | 1 | 2015 | 77 | 0.030 |
Why?
|
| North America | 1 | 2019 | 1287 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2002 | 1020 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 1996 | 323 | 0.030 |
Why?
|
| Africa | 1 | 2018 | 725 | 0.030 |
Why?
|
| Shellfish | 1 | 1995 | 37 | 0.030 |
Why?
|
| Carbohydrate Conformation | 1 | 1996 | 206 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2001 | 837 | 0.030 |
Why?
|
| Sepharose | 1 | 1996 | 100 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2022 | 14766 | 0.030 |
Why?
|
| Chitin | 1 | 2015 | 34 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2001 | 2227 | 0.030 |
Why?
|
| Transplantation, Autologous | 2 | 2001 | 2118 | 0.030 |
Why?
|
| Fever | 2 | 2000 | 1605 | 0.030 |
Why?
|
| Gene Order | 1 | 2015 | 166 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2004 | 2448 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 1997 | 392 | 0.030 |
Why?
|
| Carbohydrate Sequence | 1 | 1996 | 411 | 0.030 |
Why?
|
| Periplasm | 1 | 2015 | 43 | 0.030 |
Why?
|
| Glycosides | 1 | 1996 | 99 | 0.030 |
Why?
|
| Rumen | 1 | 2015 | 12 | 0.030 |
Why?
|
| Models, Biological | 3 | 2019 | 9464 | 0.030 |
Why?
|
| Conjugation, Genetic | 1 | 2015 | 116 | 0.030 |
Why?
|
| Introns | 1 | 1998 | 965 | 0.030 |
Why?
|
| Tryptophan-tRNA Ligase | 1 | 2015 | 16 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2022 | 883 | 0.030 |
Why?
|
| Skin Diseases, Bacterial | 1 | 1995 | 65 | 0.030 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2015 | 59 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 416 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2019 | 6260 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 1996 | 456 | 0.030 |
Why?
|
| DNA Mutational Analysis | 4 | 1992 | 4114 | 0.030 |
Why?
|
| Virus Diseases | 1 | 2021 | 722 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2004 | 1722 | 0.030 |
Why?
|
| Sepsis | 1 | 1989 | 2605 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2019 | 1639 | 0.030 |
Why?
|
| Deoxyribonuclease I | 1 | 2015 | 228 | 0.030 |
Why?
|
| Gels | 1 | 1996 | 421 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2008 | 3232 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2001 | 2201 | 0.030 |
Why?
|
| Age Factors | 3 | 2021 | 18401 | 0.030 |
Why?
|
| Calgranulin A | 1 | 2015 | 81 | 0.030 |
Why?
|
| Biopsy | 2 | 2018 | 6777 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1997 | 2168 | 0.030 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2014 | 85 | 0.030 |
Why?
|
| Bile | 1 | 1995 | 300 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2017 | 853 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 1623 | 0.030 |
Why?
|
| Arabidopsis | 1 | 1997 | 466 | 0.030 |
Why?
|
| Hospitalization | 3 | 2021 | 10815 | 0.030 |
Why?
|
| Deoxyribonucleases | 1 | 2015 | 209 | 0.030 |
Why?
|
| Macromolecular Substances | 2 | 1993 | 1430 | 0.030 |
Why?
|
| Prognosis | 5 | 2021 | 29963 | 0.030 |
Why?
|
| Heme | 1 | 1996 | 316 | 0.030 |
Why?
|
| Double-Blind Method | 3 | 2018 | 12451 | 0.030 |
Why?
|
| Graft vs Host Disease | 4 | 2002 | 3049 | 0.030 |
Why?
|
| Peer Review, Research | 1 | 2017 | 343 | 0.030 |
Why?
|
| Lethal Dose 50 | 1 | 1993 | 71 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 2010 | 1989 | 0.030 |
Why?
|
| Phenotype | 3 | 2003 | 16718 | 0.030 |
Why?
|
| Cholangitis, Sclerosing | 1 | 1995 | 179 | 0.030 |
Why?
|
| Micronutrients | 1 | 2016 | 390 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 793 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2018 | 1326 | 0.030 |
Why?
|
| Microspheres | 1 | 2016 | 774 | 0.030 |
Why?
|
| Logistic Models | 1 | 2008 | 13284 | 0.030 |
Why?
|
| Automation | 1 | 1996 | 587 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2001 | 2412 | 0.030 |
Why?
|
| Prophages | 1 | 2013 | 39 | 0.030 |
Why?
|
| Rectum | 2 | 2009 | 898 | 0.030 |
Why?
|
| Mannose-6-Phosphate Isomerase | 1 | 2012 | 5 | 0.030 |
Why?
|
| Genomic Islands | 1 | 2013 | 52 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1994 | 766 | 0.030 |
Why?
|
| Inverted Repeat Sequences | 1 | 2013 | 59 | 0.030 |
Why?
|
| Polymyxin B | 1 | 2012 | 44 | 0.030 |
Why?
|
| Antibodies | 1 | 2021 | 2419 | 0.030 |
Why?
|
| Hemagglutination | 1 | 1992 | 32 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 2017 | 697 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2019 | 1441 | 0.030 |
Why?
|
| Colon | 1 | 2001 | 1797 | 0.030 |
Why?
|
| Temperature | 1 | 1999 | 2232 | 0.030 |
Why?
|
| Dominican Republic | 1 | 2012 | 78 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2021 | 1628 | 0.030 |
Why?
|
| Viral Load | 1 | 2022 | 3385 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2001 | 8535 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2015 | 588 | 0.030 |
Why?
|
| Placebos | 1 | 2017 | 1660 | 0.030 |
Why?
|
| Point Mutation | 1 | 2017 | 1591 | 0.030 |
Why?
|
| Nepal | 1 | 2013 | 301 | 0.020 |
Why?
|
| Learning | 1 | 2022 | 1754 | 0.020 |
Why?
|
| Electrophoresis | 1 | 2012 | 226 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2015 | 898 | 0.020 |
Why?
|
| Sequence Homology | 1 | 1992 | 197 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 2 | 1992 | 187 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2013 | 398 | 0.020 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 1999 | 1023 | 0.020 |
Why?
|
| Cryptosporidium parvum | 1 | 2012 | 35 | 0.020 |
Why?
|
| Family | 2 | 2015 | 3210 | 0.020 |
Why?
|
| Genomics | 2 | 2018 | 5924 | 0.020 |
Why?
|
| Cell Line | 4 | 2012 | 15567 | 0.020 |
Why?
|
| Bacteriophage Typing | 1 | 2011 | 3 | 0.020 |
Why?
|
| Eye Infections, Fungal | 1 | 1992 | 99 | 0.020 |
Why?
|
| Retina | 1 | 2002 | 2659 | 0.020 |
Why?
|
| Disease-Free Survival | 4 | 2004 | 6844 | 0.020 |
Why?
|
| Kinetics | 1 | 2019 | 6287 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2015 | 588 | 0.020 |
Why?
|
| Biological Transport | 2 | 1993 | 2084 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2016 | 1182 | 0.020 |
Why?
|
| Paneth Cells | 1 | 2011 | 100 | 0.020 |
Why?
|
| Mass Spectrometry | 2 | 2010 | 2201 | 0.020 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2009 | 238 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 1999 | 1359 | 0.020 |
Why?
|
| Ricin | 2 | 1988 | 70 | 0.020 |
Why?
|
| Immunosuppressive Agents | 2 | 2000 | 4210 | 0.020 |
Why?
|
| Meningitis, Bacterial | 1 | 1993 | 222 | 0.020 |
Why?
|
| Citrates | 1 | 1990 | 132 | 0.020 |
Why?
|
| Shiga Toxin 2 | 1 | 1990 | 21 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 2011 | 0.020 |
Why?
|
| DNA, Protozoan | 1 | 2011 | 227 | 0.020 |
Why?
|
| Pandemics | 2 | 2020 | 8736 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2002 | 3207 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2012 | 685 | 0.020 |
Why?
|
| History, 18th Century | 1 | 2010 | 206 | 0.020 |
Why?
|
| Chickens | 1 | 1992 | 843 | 0.020 |
Why?
|
| Candidiasis | 2 | 2009 | 366 | 0.020 |
Why?
|
| Hemolysis | 1 | 1992 | 417 | 0.020 |
Why?
|
| Carbon | 1 | 1994 | 672 | 0.020 |
Why?
|
| DNA Topoisomerase IV | 1 | 2009 | 42 | 0.020 |
Why?
|
| Publishing | 1 | 2017 | 837 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 1990 | 634 | 0.020 |
Why?
|
| Gentamicins | 1 | 1991 | 244 | 0.020 |
Why?
|
| Erythromycin | 1 | 2010 | 114 | 0.020 |
Why?
|
| Radiography | 1 | 2001 | 6975 | 0.020 |
Why?
|
| Retrospective Studies | 8 | 2004 | 81659 | 0.020 |
Why?
|
| Ampicillin | 2 | 1987 | 137 | 0.020 |
Why?
|
| Brachyspira | 1 | 2009 | 3 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2011 | 292 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 26325 | 0.020 |
Why?
|
| Opportunistic Infections | 1 | 1992 | 375 | 0.020 |
Why?
|
| Zimbabwe | 1 | 2009 | 135 | 0.020 |
Why?
|
| Transplantation Conditioning | 1 | 1996 | 1601 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 2012 | 39317 | 0.020 |
Why?
|
| Tetracycline | 1 | 2010 | 216 | 0.020 |
Why?
|
| DNA Gyrase | 1 | 2009 | 86 | 0.020 |
Why?
|
| DNA | 2 | 2015 | 7210 | 0.020 |
Why?
|
| Genome, Viral | 1 | 2013 | 673 | 0.020 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2009 | 96 | 0.020 |
Why?
|
| Solubility | 1 | 1990 | 1078 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2013 | 1750 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1994 | 3052 | 0.020 |
Why?
|
| Milk | 1 | 2011 | 437 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2011 | 473 | 0.020 |
Why?
|
| Echocardiography | 1 | 2001 | 5042 | 0.020 |
Why?
|
| Bacterial Translocation | 1 | 2008 | 74 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 4349 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2013 | 877 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 1 | 2009 | 319 | 0.020 |
Why?
|
| Epidemics | 1 | 2014 | 516 | 0.020 |
Why?
|
| Endocarditis, Subacute Bacterial | 1 | 1987 | 8 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 1729 | 0.020 |
Why?
|
| Penicillins | 3 | 1991 | 404 | 0.020 |
Why?
|
| Microbiological Techniques | 1 | 2008 | 97 | 0.020 |
Why?
|
| Malnutrition | 1 | 2014 | 632 | 0.020 |
Why?
|
| Cefamandole | 1 | 1987 | 9 | 0.020 |
Why?
|
| Shigella dysenteriae | 1 | 1987 | 14 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2010 | 751 | 0.020 |
Why?
|
| Ciprofloxacin | 1 | 2009 | 313 | 0.020 |
Why?
|
| Sheep | 1 | 1990 | 1449 | 0.020 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2009 | 240 | 0.020 |
Why?
|
| Toxoids | 1 | 2007 | 11 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2015 | 10455 | 0.020 |
Why?
|
| Protein Conformation | 2 | 1992 | 3948 | 0.020 |
Why?
|
| Lepidoptera | 1 | 2007 | 24 | 0.020 |
Why?
|
| Autoantigens | 1 | 2011 | 890 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 1987 | 455 | 0.020 |
Why?
|
| Water Microbiology | 1 | 2007 | 117 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2007 | 147 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 1988 | 573 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2009 | 348 | 0.020 |
Why?
|
| Interleukin-13 | 1 | 2009 | 391 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2007 | 654 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 2 | 1998 | 831 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1988 | 705 | 0.020 |
Why?
|
| Length of Stay | 1 | 2000 | 6489 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2007 | 394 | 0.020 |
Why?
|
| Penicillin Resistance | 2 | 1983 | 77 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2004 | 22361 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2009 | 554 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 1197 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2009 | 663 | 0.020 |
Why?
|
| Treatment Outcome | 6 | 2009 | 65295 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2015 | 2856 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2015 | 3445 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2004 | 11872 | 0.020 |
Why?
|
| Prevalence | 2 | 2015 | 15851 | 0.020 |
Why?
|
| Larva | 1 | 2007 | 512 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 2007 | 739 | 0.020 |
Why?
|
| Spores, Bacterial | 1 | 2005 | 114 | 0.010 |
Why?
|
| Heart Block | 1 | 1986 | 391 | 0.010 |
Why?
|
| Mezlocillin | 1 | 1984 | 3 | 0.010 |
Why?
|
| Moxalactam | 1 | 1984 | 9 | 0.010 |
Why?
|
| Cefoperazone | 1 | 1984 | 7 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2013 | 2493 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 1987 | 899 | 0.010 |
Why?
|
| Cefotaxime | 1 | 1984 | 36 | 0.010 |
Why?
|
| Piperacillin | 1 | 1984 | 37 | 0.010 |
Why?
|
| Peroxidases | 1 | 2004 | 134 | 0.010 |
Why?
|
| Transplantation, Homologous | 2 | 2004 | 4838 | 0.010 |
Why?
|
| Cross Infection | 1 | 1993 | 1426 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2001 | 7435 | 0.010 |
Why?
|
| Aminoglycosides | 1 | 1984 | 161 | 0.010 |
Why?
|
| Muramoylpentapeptide Carboxypeptidase | 1 | 1983 | 26 | 0.010 |
Why?
|
| Genes | 1 | 1987 | 1824 | 0.010 |
Why?
|
| Tricuspid Valve | 1 | 1986 | 419 | 0.010 |
Why?
|
| Peptidyl Transferases | 1 | 1983 | 55 | 0.010 |
Why?
|
| Hexosyltransferases | 1 | 1983 | 58 | 0.010 |
Why?
|
| Clavulanic Acids | 1 | 1982 | 11 | 0.010 |
Why?
|
| Carbenicillin | 1 | 1982 | 12 | 0.010 |
Why?
|
| Clavulanic Acid | 1 | 1982 | 19 | 0.010 |
Why?
|
| Thienamycins | 1 | 1982 | 29 | 0.010 |
Why?
|
| Sulbactam | 1 | 1982 | 32 | 0.010 |
Why?
|
| Imipenem | 1 | 1982 | 38 | 0.010 |
Why?
|
| Massachusetts | 1 | 1995 | 8890 | 0.010 |
Why?
|
| Penicillanic Acid | 1 | 1982 | 41 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 2744 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2009 | 3093 | 0.010 |
Why?
|
| Gastric Acid | 1 | 2002 | 98 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2007 | 1244 | 0.010 |
Why?
|
| Tissue Donors | 2 | 2004 | 2387 | 0.010 |
Why?
|
| Americas | 1 | 2001 | 110 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2017 | 3464 | 0.010 |
Why?
|
| Kanamycin Kinase | 1 | 1981 | 34 | 0.010 |
Why?
|
| Pregnancy | 3 | 2015 | 30238 | 0.010 |
Why?
|
| Bacteriocins | 1 | 2001 | 85 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2008 | 2345 | 0.010 |
Why?
|
| Blood Group Incompatibility | 1 | 2002 | 134 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2005 | 1617 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1984 | 1697 | 0.010 |
Why?
|
| Gram-Positive Bacteria | 1 | 2001 | 180 | 0.010 |
Why?
|
| Chloramphenicol | 1 | 1980 | 67 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2014 | 4648 | 0.010 |
Why?
|
| Phosphotransferases | 1 | 1981 | 302 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2005 | 760 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1986 | 2350 | 0.010 |
Why?
|
| Skin Diseases | 2 | 1997 | 1083 | 0.010 |
Why?
|
| Graft Survival | 2 | 2001 | 3896 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3427 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2000 | 511 | 0.010 |
Why?
|
| Streptococcus pyogenes | 1 | 2001 | 293 | 0.010 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 1999 | 91 | 0.010 |
Why?
|
| ras Proteins | 1 | 2004 | 1054 | 0.010 |
Why?
|
| Apoptosis | 1 | 2015 | 9513 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2004 | 2678 | 0.010 |
Why?
|
| Bacillus subtilis | 1 | 2001 | 356 | 0.010 |
Why?
|
| Splenectomy | 1 | 1999 | 390 | 0.010 |
Why?
|
| Mitral Valve | 1 | 1986 | 1475 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 11063 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1982 | 1419 | 0.010 |
Why?
|
| Cytarabine | 1 | 1999 | 695 | 0.010 |
Why?
|
| Brain | 1 | 2004 | 27163 | 0.010 |
Why?
|
| Peptides | 1 | 2009 | 4348 | 0.010 |
Why?
|
| Heart Failure | 1 | 2001 | 11877 | 0.010 |
Why?
|
| Platelet Transfusion | 1 | 2000 | 301 | 0.010 |
Why?
|
| Cyclosporine | 1 | 1999 | 778 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1989 | 2535 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1981 | 1759 | 0.010 |
Why?
|
| Drug Eruptions | 1 | 1980 | 335 | 0.010 |
Why?
|
| Aortic Valve | 1 | 1986 | 1968 | 0.010 |
Why?
|
| Chromosome Deletion | 2 | 1992 | 1384 | 0.010 |
Why?
|
| HLA Antigens | 1 | 2002 | 1334 | 0.010 |
Why?
|
| Cell Survival | 2 | 1999 | 5750 | 0.010 |
Why?
|
| Reoperation | 1 | 1986 | 4325 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2003 | 1626 | 0.010 |
Why?
|
| Hematologic Diseases | 1 | 1980 | 498 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 2001 | 764 | 0.010 |
Why?
|
| Remission Induction | 1 | 2001 | 2408 | 0.010 |
Why?
|
| Pneumonia | 1 | 1987 | 2159 | 0.010 |
Why?
|
| Sex Factors | 2 | 1986 | 10622 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 1705 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2009 | 4546 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2009 | 8068 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2000 | 1751 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 2883 | 0.010 |
Why?
|
| Developing Countries | 1 | 2006 | 2911 | 0.010 |
Why?
|
| RNA | 1 | 2003 | 2715 | 0.010 |
Why?
|
| Aged, 80 and over | 4 | 2010 | 59548 | 0.010 |
Why?
|
| Anaphylaxis | 1 | 1980 | 738 | 0.010 |
Why?
|
| Fungemia | 1 | 1992 | 57 | 0.010 |
Why?
|
| Software | 1 | 1986 | 4472 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1993 | 383 | 0.010 |
Why?
|
| Respiratory Tract Infections | 1 | 2000 | 1009 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2002 | 2972 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1999 | 6106 | 0.010 |
Why?
|
| Drug Hypersensitivity | 1 | 1980 | 903 | 0.010 |
Why?
|
| Anticoagulants | 1 | 1986 | 4854 | 0.010 |
Why?
|
| Aspergillosis | 1 | 1992 | 241 | 0.010 |
Why?
|
| X-Ray Diffraction | 1 | 1991 | 416 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 24299 | 0.010 |
Why?
|
| Aging | 1 | 2008 | 8729 | 0.010 |
Why?
|
| Lung Diseases | 1 | 1980 | 1942 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1980 | 1660 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 1991 | 6310 | 0.000 |
Why?
|
| Kidney Diseases | 1 | 1980 | 2099 | 0.000 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1992 | 1677 | 0.000 |
Why?
|
| Liver Diseases | 1 | 1997 | 1304 | 0.000 |
Why?
|
| Pneumococcal Infections | 1 | 1993 | 529 | 0.000 |
Why?
|
| Pilot Projects | 1 | 2001 | 8732 | 0.000 |
Why?
|
| Protein Binding | 1 | 2000 | 9327 | 0.000 |
Why?
|
| Trypsin | 1 | 1988 | 490 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 2001 | 12536 | 0.000 |
Why?
|
| Chronic Disease | 1 | 2002 | 9362 | 0.000 |
Why?
|
| Lactams | 1 | 1987 | 159 | 0.000 |
Why?
|
| Glutamates | 1 | 1988 | 384 | 0.000 |
Why?
|
| Retinal Diseases | 1 | 1992 | 709 | 0.000 |
Why?
|
| Registries | 1 | 2001 | 8351 | 0.000 |
Why?
|
| Creatinine | 1 | 1991 | 1916 | 0.000 |
Why?
|
| Injections, Intravenous | 1 | 1987 | 1377 | 0.000 |
Why?
|
| Cephalothin | 1 | 1983 | 28 | 0.000 |
Why?
|
| Penicillin G | 1 | 1983 | 40 | 0.000 |
Why?
|
| Protoplasts | 1 | 1983 | 45 | 0.000 |
Why?
|
| Microscopy, Fluorescence | 1 | 1990 | 2628 | 0.000 |
Why?
|
| Actins | 1 | 1990 | 2059 | 0.000 |
Why?
|
| Urine | 1 | 1983 | 362 | 0.000 |
Why?
|
| Penicillin-Binding Proteins | 1 | 1983 | 152 | 0.000 |
Why?
|
| Boston | 1 | 1993 | 9360 | 0.000 |
Why?
|
| Seizures | 1 | 1993 | 2996 | 0.000 |
Why?
|
| Hospital Mortality | 1 | 1993 | 5345 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1988 | 5141 | 0.000 |
Why?
|
| Kidney | 1 | 1991 | 7063 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1987 | 6409 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1983 | 3642 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1987 | 8048 | 0.000 |
Why?
|